Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-01-31 Sale | 2022-02-02 4:32 pm | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 8,195 | $7.58 | $62,118 | 490,025 (Direct) | View |
| 2022-01-04 Sale | 2022-01-07 08:38 am | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 46,968 | $9.15 | $429,757 | 298,220 (Direct) | View |
| 2020-12-14 Purchase | 2020-12-15 5:27 pm | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 10,000 | $18.5 | $185,000 | 229,117 (Direct) | View |
| 2019-11-21 Purchase | 2019-11-22 3:34 pm | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 7,530 | $28 | $210,840 | 16,548 (Direct) | View |
| 2019-11-20 Purchase | 2019-11-22 1:35 pm | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 7,470 | $28 | $209,160 | 9,018 (Direct) | View |
| 2019-11-15 Purchase | 2019-11-18 7:32 pm | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 1,548 | $26 | $40,248 | 1,548 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-31 Option Award | 2024-02-02 7:04 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 87,615 | $0 | 87,615 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 5:03 pm | N/A 2033-06-13 | Allogene Therapeutics Inc. | ALLO | Barrett Elizabeth A. Director | 116,120 | $0 | 116,120 (Direct) | View |
| 2023-01-31 Exercise | 2023-02-02 3:40 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 18,333 | $0 | 640,025 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 3:40 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 300,000 | $0 | 640,025 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:57 pm | N/A 2032-06-15 | Allogene Therapeutics Inc. | ALLO | Barrett Elizabeth A. Director | 71,070 | $0 | 71,070 (Direct) | View |
| 2022-01-31 Exercise | 2022-02-02 4:32 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 18,333 | $0 | 490,025 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 4:32 pm | N/A 2032-01-31 | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 150,000 | $0 | 490,025 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-07 08:38 am | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 105,689 | $0 | 298,220 (Direct) | View |
| 2021-07-30 Option Award | 2021-08-03 5:32 pm | N/A 2031-07-30 | Allogene Therapeutics Inc. | ALLO | Barrett Elizabeth A. Director | 63,385 | $0 | 63,385 (Direct) | View |
| 2020-06-03 Exercise(A) | 2021-07-12 6:59 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 61,652 | $0 | 1,205,551 (Direct) | View |
| 2020-02-03 Exercise(A) | 2021-07-12 6:57 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 35,229 | $0 | 928,902 (Direct) | View |
| 2021-01-03 Exercise | 2021-05-21 1:44 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 13,807 | $0 | 355,188 (Direct) | View |
| 2021-05-19 Tax Withholding | 2021-05-21 1:44 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 3,425 | $17.51 | 355,188 (Direct) | View |
| 2021-01-31 Option Award | 2021-02-02 2:54 pm | N/A 2031-01-31 | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 190,000 | $0 | 190,000 (Direct) | View |
| 2020-12-04 Exercise | 2020-12-04 4:35 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 61,652 | $0 | 333,613 (Direct) | View |
Ownership | 2020-11-20 7:05 pm | N/A N/A | Lifesci Acquisition II Corp. | LSAQ | Barrett Elizabeth A. Director | 0 | $0 | 6,000 (Direct) | View |
| 2020-05-12 Exercise | 2020-05-14 1:07 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 35,229 | $0 | 333,613 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 12:36 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2020-01-03 Exercise | 2020-01-07 6:30 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 105,688 | $0 | 333,613 (Direct) | View |